Clinical Trial Update: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of a fixed-dose combination of olmesartan medoxomil, amlodipine, and hydrochlorothiazide in patients with hypertens…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Olmesartan medoxomil amlodipine and hydrochlorothiazide (olmesartan medoxomil; amlodipine; hydrochlorothiazide)

Snippet

Sponsor: Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED